skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Academic Search Premier (EB_SDU_P3) remover assunto: Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702

OKAMOTO, H ; WATANABE, K ; KUNIKANE, H ; YOKOYAMA, A ; KUDOH, S ; ASAKAWA, T ; SHIBATA, T ; KUNITOH, H ; TAMURA, T ; SAIJO, N

British journal of cancer, 2007-07, Vol.97 (2), p.162-169 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer

Li, Lijuan ; Yang, Dan ; Min, Yanmei ; Liao, Anyan ; Zhao, Jing ; Jiang, Leilei ; Dong, Xin ; Deng, Wei ; Yu, Huiming ; Yu, Rong ; Zhao, Jun ; Shi, Anhui

BMC cancer, 2023-04, Vol.23 (1), p.318-318, Article 318 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma
Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma

Xin, Xiangke ; Lin, Li ; Yang, Yang ; Wang, Na ; Wang, Jue ; Xu, Jinhuan ; Wei, Jia ; Huang, Liang ; Zheng, Miao ; Xiao, Yi ; Meng, Fankai ; Cao, Yang ; Zhu, Xiaojian ; Zhang, Yicheng

Cytotherapy (Oxford, England), 2024-05, Vol.26 (5), p.456-465 [Periódico revisado por pares]

England: Elsevier Inc

Texto completo disponível

Citações Citado por
4
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

Morgensztern, Daniel ; Rose, Michal ; Waqar, Saiama N ; Morris, John ; Ma, Patrick C ; Reid, Thomas ; Brzezniak, Christina E ; Zeman, Karen G ; Padmanabhan, Arvinda ; Hirth, JoAnn ; I Spira, Alexander ; Trepel, Jane B ; Padda, Sukhmani K

British journal of cancer, 2019-07, Vol.121 (3), p.211-217 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

REARDON, D. A ; DESJARDINS, A ; FRIEDMAN, A. H ; BIGNER, D. D ; FRIEDMAN, H. S ; VREDENBURGH, J. J ; GURURANGAN, S ; SAMSON, J. H ; SATHORNSUMETEE, S ; MCLENDON, R. E ; HERNDON, J. E ; MARCELLO, J. E ; NORFLEET, J

British journal of cancer, 2009-12, Vol.101 (12), p.1986-1994 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide

Turk, Seyhan ; Turk, Can ; Akbar, Muhammad Waqas ; Kucukkaraduman, Baris ; Isbilen, Murat ; Demirkol Canli, Secil ; Malkan, Umit Yavuz ; Okay, Mufide ; Ucar, Gulberk ; Sayinalp, Nilgun ; Haznedaroglu, Ibrahim Celalettin ; Gure, Ali Osmay Bertolini, Francesco

PloS one, 2020-11, Vol.15 (11), p.e0242497 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
7
Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy
Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy

Morimoto, Kenji ; Yamada, Tadaaki ; Takeda, Takayuki ; Shiotsu, Shinsuke ; Date, Koji ; Harada, Taishi ; Tamiya, Nobuyo ; Chihara, Yusuke ; Takemura, Yoshizumi ; Yamada, Takahiro ; Kanda, Hibiki ; Ishida, Masaki ; Yoshimura, Akihiro ; Iwasaku, Masahiro ; Tokuda, Shinsaku ; Kim, Young Hak ; Takayama, Koichi

Drugs & aging, 2023-06, Vol.40 (6), p.563-571 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
8
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720
Material Type:
Artigo 		Adicionar ao Meu Espaço

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

BALER, M. R ; GEORGE, S. L ; LARSON, R. A ; SANFORD, B. L ; MROZEK, K ; KOLITZ, J. E ; MOORE, J. O ; STONE, R. M ; POWELL, B. L ; CALIGIURI, M. A ; BLOOMFIELD, C. D

Leukemia, 2011-05, Vol.25 (5), p.800-807 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)
Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)

Chan Wah Hak, Charleen ; Coyle, Christopher ; Kocache, Arwa ; Short, Dee ; Sarwar, Naveed ; Seckl, Michael J ; Gonzalez, Michael A

BMC cancer, 2019-08, Vol.19 (1), p.770-770, Article 770 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
10
Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma

Desai, A V ; Heneghan, M B ; Li, Y ; Bunin, N J ; Grupp, S A ; Bagatell, R ; Seif, A E

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1204-1210 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (2.524)

Data de Publicação 

De até
Refinar
  1. Antes de1991  (74)
  2. 1991Até1998  (382)
  3. 1999Até2006  (775)
  4. 2007Até2015  (885)
  5. Após 2015  (429)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (220)
  2. Russo  (2)
  3. Serbian  (2)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.